SKSoichi Komaki

Soichi Komaki

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Soichi Komaki has a total of 90 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Determinants and Clinical Interpretation of Circulating Transthyretin in ATTR Amyloidosis

    by Toshihiro Tsuruda, Yosuke Suiko, Yunosuke Matsuura, Soichi Komaki, Kohei Moribayashi, Hiroki Tanaka, Masashi Yamaguchi, Kinuko Yamamoto, Michikazu Nakai, Koichi Kaikita

  • Open Access

    Severe Functional Tricuspid Regurgitation Masked by Annular Deformation in Primary Cardiac Lymphoma

    by Toshiki Tanahashi, Kohei Moribayashi, Yunosuke Matsuura, Kinuko Yamamoto, Hiroki Tanaka, Soichi Komaki, Atsushi Kisanuki, Atsushi Yamashita, Nozomi Watanabe, Koichi Kaikita


  • Open Access

    Association between diabetes and in‐hospital outcomes in patients with metabolic dysfunction‐associated steatotic liver disease hospitalized for cardiovascular disease: A nationwide database study

    by Soichi Komaki, Michikazu Nakai, Yunosuke Matsuura, Kinuko Yamamoto, Hiroki Tanaka, Yuri Komaki, Masashi Yamaguchi, Kohei Moribayashi, Takeshi Ideguchi, Hiroshi Kawakami, et al.

    Aims: To evaluate the impact of diabetes on in‐hospital outcomes among patients with metabolic dysfunction‐associated steatotic liver disease (MASLD) who were hospitalized for cardiovascular disease (CVD). Methods: We conducted a retrospective cross‐sectional study using data from the nationwide Japanese Registry of All Cardiac and Vascular Diseases‐Diagnosis Procedure Combination, from April 2012 to March 2023. A total of 10,614 patients with MASLD hospitalized for CVD were identified, of whom 4550 (42.9%) had diabetes. The primary outcome was in‐hospital mortality, and secondary outcomes were major cardiac and non‐cardiac complications. Results: The median age was 66 years, and 66.9% were male. Compared with patients without diabetes, those with diabetes had higher rates of ischaemic heart disease (35.5% vs. 30.8%), acute coronary syndrome (18.8% vs. 16.9%) and heart failure (27.3% vs. 25.4%) (all p < 0.05). In‐hospital mortality (5.6% vs. 3.3%; p < 0.001) and overall complication rates (23.6% vs. 19.7%; p < 0.001) were significantly greater in the diabetes group, driven mainly by cardiac events (16.8% vs. 10.5%; p < 0.001). Multivariable logistic regression confirmed diabetes as an independent predictor of in‐hospital mortality (odds ratio, 1.99; 95% confidence interval, 1.60–2.47; p < 0.001). Conclusions: Diabetes was associated with higher in‐hospital mortality and complication rates among patients with MASLD hospitalized for CVD. Stratification of MASLD by metabolic phenotype, particularly in the presence of diabetes, may help improve risk assessment and inform more personalized clinical management in this population.

  • Open Access

    Exercise Stress Echocardiography–Guided Balloon Pulmonary Valvuloplasty for Pulmonary Valve Stenosis With a Moderate Pressure Gradient and Exercise Intolerance: A Case Report

    by Soichi Komaki, Yoshihiko Kodama, Kohei Kurogi, Kinuko Yamamoto, Takeshi Ideguchi, Yunosuke Matsuura, Hiroshi Moritake, Koichi Kaikita

    Current guidelines recommend balloon pulmonary valvuloplasty (BPV) for symptomatic adults with moderate or severe pulmonary valve stenosis (PVS) when the valve anatomy is suitable. However, when the resting gradient is near the lower boundary of the moderate range, establishing whether exercise intolerance is attributable to PVS can be challenging. We describe the case of a 52‐year‐old woman with longstanding PVS who developed progressive exercise intolerance. Resting echocardiography revealed a peak gradient of 38 mmHg, which remained stable during follow‐up. Exercise stress echocardiography (ESE) demonstrated a blunted stroke volume response, whereas cardiopulmonary exercise testing (CPET) showed reduced peak VO 2 . Based on these objective findings, BPV was performed for symptomatic moderate PVS. Following successful intervention, both the stroke volume response and peak VO 2 improved markedly. This case highlights that exercise‐based diagnostic modalities, particularly ESE in conjunction with CPET, can help guide treatment decisions in symptomatic moderate PVS.

  • Coronary computed tomography angiography radiomics for predicting major adverse cardiovascular events after percutaneous coronary interventions

    by Soichi Komaki, Yunosuke Matsuura, Yoshikazu Uchiyama, Shintaro Izumoto, Hiroki Tanaka, Masashi Yamaguchi, Kohei Moribayashi, Kazumasa Kurogi, Nobuyasu Yamamoto, Michikazu Nakai, et al.


  • Open Access

    Nitroglycerin use and adverse clinical outcomes in elderly patients with acute coronary syndrome

    by Soichi Komaki, Yunosuke Matsuura, Hiroki Tanaka, Kohei Moribayashi, Yoshimasa Yamamura, Kazumasa Kurogi, Takeshi Ideguchi, Nobuyasu Yamamoto, Michikazu Nakai, Toshihiro Tsuruda, et al.

    Objective The primary care for acute coronary syndrome (ACS) includes the administration of nitroglycerin (GTN). This study aimed to investigate the association between the use of GTN before percutaneous coronary intervention (PCI) for ACS and clinical outcomes. Methods Nine-hundred and forty-seven patients who underwent PCI for ACS were examined and classified into two groups: those who were treated with GTN before PCI (GTN group) and those who were not (non-GTN group). The incidence of major adverse cardiovascular events (MACE), which consist of all-cause mortality, non-fatal myocardial infarction, stroke and rehospitalisation for heart failure at 1 year, was compared between the two groups. Results This study identified 289 patients with ACS who used GTN preceding PCI. Pre-PCI systolic blood pressure was significantly lower in the GTN group than in the non-GTN group (median (IQR); 132.0 (110.0–143.5) mm Hg vs 134.0 (112.0–157.0) mm Hg, respectively, p=0.03). Multivariate Cox regression analysis indicated that GTN use preceding PCI showed an independent association with the incidence of MACE (HR 1.57; 95% CI 1.09–2.28; p=0.016). Overall, the incidence of MACE 1 year after PCI for ACS was significantly higher in the GTN group than in the non-GTN group (log-rank test, p=0.024); however, this trend was consistently found in elderly patients aged ≥75 years (p=0.002) but not in non-elderly patients aged Conclusions GTN use preceding PCI for ACS is associated with lower blood pressure and adverse clinical outcomes in elderly patients.


  • Open Access

    Very Late Stent Thrombosis Complicating Immune Thrombocytopenia

    by Hisanobu Shimazu, Yunosuke Matsuura, Kohei Moribayashi, Toshihiro Gi, Yosuke Suiko, Hiroki Tanaka, Soichi Komaki, Tetsunori Ishikawa, Atsushi Yamashita, Koichi Kaikita


  • Open Access

    Nitroglycerin use preceding primary percutaneous coronary intervention is associated with adverse clinical outcomes in elderly patients with acute coronary syndrome

    by Soichi Komaki, Yunosuke Matsuura, Hiroki Tanaka, Kohei Moribayashi, Yoshimasa Yamamura, Kazumasa Kurogi, Takeshi Ideguchi, Nobuyasu Yamamoto, Michikazu Nakai, Toshihiro Tsuruda, et al.

    Background: The primary care for acute coronary syndrome (ACS) includes the administration of nitroglycerin (GTN). This study aimed to investigate the association between the use of GTN before percutaneous coronary intervention (PCI) for ACS and clinical outcomes. Methods and Results: Nine-hundred and forty-seven patients who underwent PCI for ACS were examined and classified into two groups: those who were treated with GTN before PCI (GTN group) and those who were not (non-GTN group). The incidence of major adverse cardiovascular events (MACE), which consist of all-cause mortality, myocardial infarction, stroke, and rehospitalization for heart failure at 1 year, was compared between the two groups. This study identified 289 patients with ACS who used GTN preceding PCI. Pre-PCI systolic blood pressure was significantly lower in the GTN group than in the non-GTN group (median (interquartile range); 130.0 (112.5-144.2) mmHg vs. 142.0 (115.0-160.0) mmHg, respectively, p = 0.03). Multivariate Cox regression analysis indicated that GTN use preceding PCI was an independent determinant for the incidence of MACE (hazard ratio, 1.64; 95% confidence interval, 1.17-2.31; p = 0.004). Overall, the incidence of MACE 1 year after PCI for ACS was significantly higher in the GTN group than in the non-GTN group (log-rank test, p = 0.02); however, this trend was consistently found in elderly patients aged ≥ 75 years (p = 0.002) but not in non-elderly patients aged < 75 years (p = 0.77). Conclusions: GTN use preceding PCI for ACS is associated with lower blood pressure and adverse clinical outcomes in elderly patients.

  • Open Access

    Content

    by Junichi Yamaguchi, Tetsuya Matoba, Migaku Kikuchi, Yuichiro Minami, Sunao Kojima, Hiroyuki Hanada, Toshiaki Mano, Takahiro Nakashima, Katsutaka Hashiba, Takeshi Yamamoto, et al.

    Access full-text academic articles: J-STAGE is an online platform for Japanese academic journals.